These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2723771)

  • 1. Quantitative structure-activity relationship study on some dihydropteridine reductase inhibitors.
    Babbar R; Gupta JK; Gupta SP
    J Enzyme Inhib; 1989; 2(4):231-7. PubMed ID: 2723771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Gessner W; Brossi A; Shen R; Abell CW
    J Med Chem; 1985 Mar; 28(3):311-7. PubMed ID: 3871859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs.
    Abell CW; Shen RS; Gessner W; Brossi A
    Science; 1984 Apr; 224(4647):405-7. PubMed ID: 6608790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydropteridine reductase by catechol estrogens.
    Shen RS; Abell CW
    J Neurosci Res; 1983; 10(3):251-9. PubMed ID: 6315964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dihydropteridine reductase in rat striatal synaptosomes and from human liver by metabolites of biogenic amines.
    Shen RS
    J Enzyme Inhib; 1985; 1(1):61-6. PubMed ID: 3880425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-derived tetrahydroisoquinolines. Novel inhibitors of dihydropteridine reductase.
    Shen R; Smith RV; Davis PJ; Brubaker A; Abell CW
    J Biol Chem; 1982 Jul; 257(13):7294-7. PubMed ID: 7085626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat striatal synaptosomes as a model system for studying the inhibition of dihydropteridine reductase activity.
    Shen RS; Abell CW
    J Enzyme Inhib; 1987; 1(3):223-9. PubMed ID: 3508913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology of Parkinson's disease.
    Lancet; 1984 Jan; 1(8369):167. PubMed ID: 6140477
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat liver dihydropteridine reductase inhibition.
    Purdy SE; Blair JA
    Biochem Soc Trans; 1980 Oct; 8(5):565-6. PubMed ID: 7450227
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of a photolabile NADH analog with rat liver dihydropteridine reductase.
    Webber S; Baumgartner K; Blair JN; Whiteley JM
    Biochem Pharmacol; 1988 Jul; 37(14):2869-72. PubMed ID: 3395364
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of dihydropteridine reductase by catecholamines and related compounds.
    Shen RS
    Biochim Biophys Acta; 1983 Feb; 743(1):129-35. PubMed ID: 6824696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dihydropteridine reductase by dopamine.
    Purdy SE; Blair JA; Barford PA
    Biochem J; 1981 Jun; 195(3):769-71. PubMed ID: 7316984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aluminum and dihydropteridine reductase in Alzheimer's disease].
    Fuchs D; Werner ER; Wachter H
    Dtsch Med Wochenschr; 1988 May; 113(21):877. PubMed ID: 3371217
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of nomifensine and its metabolites on dihydropteridine reductase.
    Shen RS; Sheng WL; Abell CW
    J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic properties of NADPH-specific dihydropteridine reductase from bovine liver.
    Nakanishi N; Hasegawa H; Akino M; Yamada S
    J Biochem; 1986 Mar; 99(3):645-52. PubMed ID: 3711040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum and dihydropteridine reductase in dialysis patients.
    N Engl J Med; 1987 Dec; 317(25):1604-6. PubMed ID: 3683500
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of specific amino acid modifications on the catalytic properties of rat liver dihydropteridine reductase.
    Webber S; Whiteley JM
    Arch Biochem Biophys; 1981 Jan; 206(1):145-52. PubMed ID: 7212713
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydropteridine reductase (DHPR), its cofactors, and its mode of action.
    Armarego WL; Randles D; Waring P
    Med Res Rev; 1984; 4(3):267-321. PubMed ID: 6379341
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
    Shen RS; Smith RV; Davis PJ; Abell CW
    J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.